Cigall Kadoch

Insider Reports History

Entity
Individual
Location
100 Binney Street, Suite 610, Cambridge, MA
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cigall Kadoch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Director Common Stock 3.33M $27.5M $8.25 Aug 31, 2022 Indirect
Foghorn Therapeutics Inc. Director Common Stock 295K $2.43M $8.25 Aug 31, 2022 Direct
Foghorn Therapeutics Inc. Director Stock Options (Right to buy) 12.5K $38.3K $3.06 Aug 31, 2022 Direct

Insider Reports Filed by Cigall Kadoch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. Aug 31, 2022 0 $0 4 Sep 2, 2022 Director
FHTX Foghorn Therapeutics Inc. Jun 21, 2022 1 $0 4 Jun 22, 2022 Director, 10%+ Owner
FHTX Foghorn Therapeutics Inc. Dec 14, 2021 1 $0 4 Dec 16, 2021 Director, 10%+ Owner
FHTX Foghorn Therapeutics Inc. Jul 13, 2021 1 $0 4 Jul 14, 2021 Director, 10%+ Owner